Login / Signup

Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs.

Fares Al MohamadValeria Rios RodriguezHildrun HaibelMikhail ProtopopovJudith RademacherJoachim SieperMurat TorğutalpHenriette KädingFabian ProftDenis Poddubnyy
Published in: RMD open (2024)
Both NoP and NP components seem to be associated with residual symptoms in patients with r-axSpA receiving treatment with bDMARDs.
Keyphrases
  • neuropathic pain
  • spinal cord
  • spinal cord injury
  • rheumatoid arthritis
  • sleep quality
  • ankylosing spondylitis
  • disease activity
  • systemic lupus erythematosus
  • combination therapy